Systemic and local toxicity in the rat of methyl tert-butyl ether: a gallstone dissolution agent. 1992

R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
First Department of Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Methyl tert-butyl ether (MTBE) is an organic solvent that has been used to dissolve gallstones via a percutaneous transhepatic catheter into the gallbladder. To test whether MTBE might cause serious tissue injury if accidentally infused outside the gallbladder, the effect of MTBE (0.2 ml/kg) injected into the hepatic parenchyma, or administered intravenously or intraperitoneally, was examined in the rat. The toxicity of isopropyl acetate (IPA), an organic solvent with a similar chemical structure, was examined similarly. Intracaval injection of MTBE caused the highest mortality (100%). Mortality was less (59%) after intrahepatic injection and still less (17%) after peripheral vein injection. Most animals died instantaneously from cardiorespiratory arrest. Almost all animals that were injected with MTBE intrahepatically or intravenously showed localized areas of congestion, hemorrhage, and interstitial edema in the lungs. These changes were more severe in rats which survived for 24 hr than in those which died sooner. In those rats receiving intrahepatic injections, most rats which survived for 24 hr had liver necrosis at the site of injection. Intraperitoneal injection of MTBE produced 100% survival with only 1/5 rats showing a mild pulmonary injury at autopsy. IPA had toxic effects similar to those evoked by MTBE. To test whether tumor necrosis factor was involved in organ injury, serum levels were measured; they remained unchanged. These experiments indicate that two organic solvents, MTBE and IPA, are cytotoxic to local tissues and cause severe, and often fatal, lung damage when infused into a central vein. Less toxicity occurred if solvents were given into a peripheral or portal vein or intraperitoneally.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008738 Methyl Ethers A group of compounds that contain the general formula R-OCH3. Ethers, Methyl
D002769 Cholelithiasis Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS). Gallstone Disease,Cholelithiases,Gallstone Diseases
D004987 Ethers Organic compounds having two alkyl or aryl groups bonded to an oxygen atom, as in the formula R1–O–R2.
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
December 1997, Risk analysis : an official publication of the Society for Risk Analysis,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
June 1994, Digestive diseases and sciences,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
August 1995, Digestive diseases and sciences,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
June 1991, Gastroenterology,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
May 1990, Gastroenterology,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
February 1991, Digestive diseases and sciences,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
November 1990, Australasian radiology,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
June 1990, Recenti progressi in medicina,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
July 1990, AJR. American journal of roentgenology,
R Akimoto, and E Rieger, and A R Moossa, and A F Hofmann, and H E Wahlstrom
April 1986, AJR. American journal of roentgenology,
Copied contents to your clipboard!